Category: Colon Cancer

Access precision medicine for better care of your colorectal cancer patients

Immunoscore® included in ESMO Clinical Practice Guidelines 2020 Access precision medicine for better care of your patients. Add the immune parameter to your TNM scoring and get a complete picture of your patients’ risk profile. Immunoscore® enhances the therapeutic decision-making Immunoscore® is a very effective solution easy to implement in your clinical practice    … Read more »

Improving CRC patient triage in the COVID-19 era with Immunoscore®

Update 17 August 2022 – Everything Genetic no longer provides this testing service. Immunoscore® and COVID-19 Colorectal Cancer Guidelines Improving CRC patient triage in the COVID-19 era with Immunoscore®   In response to COVID-19 pandemic, the major international cancer societies and national health authorities issued a flurry of guidelines for the management of cancer patients… Read more »

Immune response is now part of the essential and desirable diagnostic criteria for colorectal cancers in the 5th edition of The WHO Classification of Tumours

Update 17 August 2022 – Everything Genetic no longer provides this testing service. The World Health Organization (WHO), in its latest edition of the Digestive System Tumours (5th edition), introduced immune response as an essential and desirable diagnostic criteria for colorectal cancer, in addition to traditional histological parameters. Commercialised by HalioDx in more than 20 countries… Read more »